Literature DB >> 23765566

Experiences and perceptions of patients living with hepatitis C in Karachi, Pakistan.

Noureen Shehzad Jiwani1, Raisa Begum Gul, Asho Ali, Mohammad Salih, Mehnaz Hanzala.   

Abstract

PURPOSE: Hepatitis C (HCV) is a chronic disease that affects an individual's physical, financial, social, and emotional well-being throughout the illness. Although extensive literature is available on experiences of patients with hepatitis C in developed countries, very little exists in developing countries, particularly in Pakistan. This article describes experiences of patients living with HCV in Karachi, Pakistan.
METHOD: Using descriptive exploratory
DESIGN: The three categories-perceptions and misperceptions, challenges and sufferings, support and shortcomings-were subsumed under the theme "deadly, dangerous, and devastating." CONCLUSION AND IMPLICATIONS FOR PRACTICE: Patients with HCV experience profound challenges that are influenced by their level of education, financial capacity, cultural norms, family support, and the sensitivity of health care professionals. Several cultural practices existing in Pakistan identify the need for public awareness. The findings on health care professionals have implications for nursing and allied health continuing education.

Entities:  

Keywords:  Pakistan; health care; hepatitis C; lived experience; stigma

Mesh:

Year:  2013        PMID: 23765566     DOI: 10.1177/1043659613481674

Source DB:  PubMed          Journal:  J Transcult Nurs        ISSN: 1043-6596            Impact factor:   1.959


  2 in total

1.  How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study.

Authors:  Shu-Mei Tsai; Jung-Ta Kao; Yun-Fang Tsai
Journal:  BMC Health Serv Res       Date:  2016-07-11       Impact factor: 2.655

Review 2.  Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.

Authors:  Laura E Dowsett; Stephanie Coward; Diane L Lorenzetti; Gail MacKean; Fiona Clement
Journal:  Can J Gastroenterol Hepatol       Date:  2017-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.